Bayesian semiparametric meta‐analytic‐predictive prior for historical control borrowing in clinical trials. (13th April 2021)

• Record Type: Journal Article
• Authors: Hupf, Bradley; Bunn, Veronica; Lin, Jianchang; Dong, Cheng
• Is Part Of: Statistics in medicine. Volume 40:Number 14(2021)
• Page Start: 3385
• Page End: 3399
• Publication Date: 2021-04-13
• Subjects: Bayesian semiparametric -- borrowing -- Dirichlet process -- hierarchical model -- historical data -- meta‐analytic‐predictive prior; Medical statistics -- Periodicals; Statistique médicale -- Périodiques; Statistiques médicales -- Périodiques; 610.727
• DOI: 10.1002/sim.8970
• Languages: English
• ISSNs: 0277-6715

Abstract

Abstract : When designing a clinical trial, borrowing historical control information can provide a more efficient approach by reducing the necessary control arm sample size while still yielding increased power. Several Bayesian methods for incorporating historical information via a prior distribution have been proposed, for example, (modified) power prior, (robust) meta‐analytic predictive prior. When utilizing historical control borrowing, the prior parameter(s) must be specified to determine the magnitude of borrowing before the current data are observed. Thus, a flexible prior is needed in case of heterogeneity between historic trials or prior data conflict with the current trial. To incorporate the ability to selectively borrow historic information, we propose a Bayesian semiparametric meta‐analytic‐predictive prior. Using a Dirichlet process mixture prior allows for relaxation of parametric assumptions, and lets the model adaptively learn the relationship between the historic and current control data. Additionally, we generalize a method for estimating the prior effective sample size (ESS) for the proposed prior. This gives an intuitive quantification of the amount of information borrowed from historical trials, and aids in tuning the prior to the specific task at hand. We illustrate the effectiveness of the proposed methodology by comparing performance between existing methods in an extensive simulation study and a phase II proof‐of‐concept trial in ankylosing spondylitis. In summary, our proposed robustification of the meta‐analytic‐predictive prior alleviates the need for prespecifying the amount of borrowing, providing a more flexible and robust method to integrate historical data from multiple study sources in the design and analysis of clinical trials.